Background: HIV+HBV+ co-infected patients (pts) are at risk of hepatic disease progression, despite effective treatment. The dysregulation of the immune response in HIV may affect the course of HBV disease. Given that invariant Natural Killer T (iNKT) cells mediate viral liver disease and HIV infection, we hypothesized a role for this cell subset in HIV+HBV+ co-infection.
Methods: Cross-sectional study: a) HIV+HBV+ (10 pts treated with TDF/FTC; 4 naïve pts); b) HIV+ (10 treated pts, 5 naive pts); c) HBV+ (9 treated pts; 5 naïve pts); d) HIV-HBV- (5 pts). iNKT frequency (CD3+Vα24+CD1d+), CD161 expression and TNF-α/IFN-γ release prior to and after PMA/Ionomycin and αGalactosylCeramide (αGalCer) were measured by flow cytometry. Kruskal-Wallis and Wilcoxon tests were used for statistics.
Results: In HIV+HBV+, a negative correlation was found between AST levels and cytokine release upon αGalCer (TNF-α: p=0.014, r=-0.65; IFN-γ: p=0.06, r=-0.53). No other significant correlations were found between iNKT phenotype/function and liver function enzymes in the other groups. To better understand the uniqueness of iNKT cells in HIV+HBV+ co-infection versus HIV and HBV infections alone, we conducted a comparative analysis of iNKT cell frequency, phenotype and function among study groups according to their treatment status (i.e. therapy-naïve and treatment-experienced subjects).
Therapy-naïve (mono-infected HBV or HIV and co-infected) showed similar circulating iNKT cells (p=0.46), CD161 expression (p=0.3), IFN-γ (unstimulated, p=0.6; PMA/Iono p=0.8; αGalCer p=0.07) and TNF-α production (us, p=0.09; PMA/Iono p=0.4; αGalCer, p= 0.9) to HIV-HBV- uninfected controls.
Treated subjects showed comparable iNKT frequencies (p=0.8) and CD161 expression (p=0.9) among study groups. Interestingly, HIV-infected individuals showed a peculiar functional capacity of iNKT cells. Indeed, mono-infected HIV+ showed the highest constitutive release of TNF-α (77%, IQR; 69-86; p=0.008) and PMA/Iono-stimulated IFN-γ production (85%, IQR: 77-94; p=0.009). Further, only iNKT cells from co-infected HIV+HBV+ significantly increased TNF-α release after αGalCer (p=0.04). No statistical differences were registered in terms of iNKT function in HBV mono-infection.
Conclusions: The inverse correlation between iNKT and liver function in HIV+HBV+ suggests the impairment of circulating iNKT cells in response to increased liver inflammation. HIV, yet not HBV, appears to be the main driver of iNKT activation in HIV+HBV+ co-infected subjects on treatment.